1. Volume 379, Issue 9813, Pages 322-334 (January 2012)
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data 
Dr Carl Heneghan, DPhil, Alison Ward, PhD, Rafael Perera, DPhil, Clare Bankhead, DPhil, Alice Fuller, BSc, Richard Stevens, PhD, Kairen Bradford, MA, Sally Tyndel, PhD, Pablo Alonso-Coello, PhD, Prof Jack Ansell, MD, Rebecca Beyth, MD, Artur Bernardo, MD, Thomas Decker Christensen, DMSc, Manon Cromheecke, PhD, Robert G Edson, MA, Prof David Fitzmaurice, MD, Alain PA Gadisseur, PhD, Josep M Garcia-Alamino, RN, Chris Gardiner, PhD, Prof Michael Hasenkam, DMSc, Alan Jacobson, MD, Scott Kaatz, DO, Prof Farhad Kamali, PhD, Tayyaba Irfan Khan, PhD, Eve Knight, DipHPsych, Heinrich Körtke, PhD, Marcel Levi, PhD, Prof David Bruce Matchar, MD, Bárbara Menéndez-Jándula, MD, Ivo Rakovac, PhD, Christian Schaefer, Prof Andrea Siebenhofer, MD, Juan Carlos Souto, PhD, Prof Rubina Sunderji, PharmD, Prof Kenneth Gin, FRCPC, Prof Karen Shalansky, PharmD, Prof Heinz Völler, MD, Otto Wagner, MSc, Prof Armin Zittermann, PhD 
The Lancet 
Volume 379, Issue 9813, Pages (January 2012)
DOI: /S (11)
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1 Flow chart of studies
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2 Hazard ratios for major outcomes
Hazard ratios for thrombotic events (152 events in the control group, 114 in the self-monitoring group; A), haemorrhagic events (244 in the control group, 230 in the self-monitoring group; B), and death (274 in the control group, 247 in the self-monitoring group; C).
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

4. Figure 3
Major outcomes by sex, age, indication, type of monitoring and control group care
Thrombosis (A), major haemorrhage (B), and death (C). O–E=observed minus expected.
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

5. Figure 4
Comparison by type of monitoring (self-monitoring compared with self-testing only)
Thrombosis (A), major haemorrhage (B), and death (C).
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

6. Figure 5
Major outcomes in mechanical valve and atrial fibrillation by age and sex
Patients with mechanical valve by sex and age (<65 years and ≥65 years; A) and patients with atrial fibrillation by sex and age (<65 years and ≥65 years; B). O–E=observed minus expected.
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions